268 related articles for article (PubMed ID: 25879466)
1. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
[TBL] [Abstract][Full Text] [Related]
2. Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.
Nowakowski A; Śliwczyński A; Seroczyński P; Cybulski M; Teter Z
Cent Eur J Public Health; 2016 Jun; 24(2):163-8. PubMed ID: 27178030
[TBL] [Abstract][Full Text] [Related]
3. HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Glinska P; Komerska K; Janik B; Olkowicz J; Jedrzejewska I; Macios A; Wieszczy P; Kaminski MF; Arbyn M; Nowakowski A
BMC Cancer; 2023 Nov; 23(1):1118. PubMed ID: 37978452
[TBL] [Abstract][Full Text] [Related]
4. Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?
Nowakowski A; Wojciechowska U; Wieszczy P; Cybulski M; Kamiński MF; Didkowska J
Eur J Epidemiol; 2017 Jun; 32(6):529-532. PubMed ID: 28780640
[TBL] [Abstract][Full Text] [Related]
5. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines.
Basu P; Nessa A; Majid M; Rahman JN; Ahmed T
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):131-4. PubMed ID: 20659365
[TBL] [Abstract][Full Text] [Related]
7. 'Organised' cervical screening 45 years on: How consistent are organised screening practices?
Williams JH; Carter SM; Rychetnik L
Eur J Cancer; 2014 Nov; 50(17):3029-38. PubMed ID: 25282406
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening: A Slovenian experience.
Primic-Zakelj M; Repse-Fokter A
Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
[TBL] [Abstract][Full Text] [Related]
10. Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence.
Martín-López R; Hernández-Barrera V; de Andres AL; Carrasco-Garrido P; de Miguel AG; Jimenez-Garcia R
Eur J Cancer Prev; 2012 Jan; 21(1):82-8. PubMed ID: 22129658
[TBL] [Abstract][Full Text] [Related]
11. [Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity].
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):39-54. PubMed ID: 23293270
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
[TBL] [Abstract][Full Text] [Related]
13. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
[TBL] [Abstract][Full Text] [Related]
14. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
15. Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.
Salo H; Nieminen P; Kilpi T; Auranen K; Leino T; Vänskä S; Tiihonen P; Lehtinen M; Anttila A
Int J Cancer; 2014 Jul; 135(1):204-13. PubMed ID: 24347441
[TBL] [Abstract][Full Text] [Related]
16. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
Hølund B; Grinsted P
Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
[TBL] [Abstract][Full Text] [Related]
17. Management of abnormal pap smear--consensus guidelines of the National Cervical Cancer Screening Programme in Poland Coordinating Centre, the Polish Gynaecological Society, the Polish Society of Pathologists, and Polish Society of Colposcopy and Uterine Cervix Pathology.
; ; ;
Ginekol Pol; 2009 Feb; 80(2):129-38. PubMed ID: 19338211
[No Abstract] [Full Text] [Related]
18. Effectiveness of the National Population-Based Cervical Cancer Screening Programme in Poland--outcomes, problems and possible solutions 7 years after implementation.
Januszek-Michalecka L; Nowak-Markwitz E; Banach P; Spaczynski M
Ann Agric Environ Med; 2013; 20(4):859-64. PubMed ID: 24364469
[TBL] [Abstract][Full Text] [Related]
19. Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2009 activity.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2011; 35(5-6 Suppl 5):39-54. PubMed ID: 22166349
[TBL] [Abstract][Full Text] [Related]
20. Cervical screening in the UK and laboratory quality control in the context of the 2007 European guidelines.
Herbert A
Coll Antropol; 2007 Apr; 31 Suppl 2():41-6. PubMed ID: 17598504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
